A Broad Range High-Throughput Assay for Lenvatinib Using Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry With Clinical Application in Patients With Hepatocellular Carcinoma
Yoshio Sueshige(Oita University Hospital), Hiroki Itoh(Oita University Hospital), Masanori Tokoro(Oita University), Kazunari Murakami(Oita University), Masataka Seike(Oita University), Koichi Honda(Yamagata University), Masao Iwao, Ryota Tanaka(Oita University Hospital), Mizuki Endo(Oita University), Mie Arakawa(Oita University), Ken Shiraiwa(Oita University Hospital), Tomoko Saito(Oita University), Ryosuke Tatsuta(Oita University Hospital)
Cited by 11
Related Papers
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
|Digestive Endoscopy|2013|469
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
|Digestive Endoscopy|2018|261
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
|Journal of Gastroenterology|2018|242